Precision Biosciences (DTIL) director receives grant of 20,979 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Pire Shari Lisa reported acquisition or exercise transactions in this Form 4 filing.

PRECISION BIOSCIENCES INC director Shari Lisa Pire received a new equity grant. She was awarded 20,979 restricted stock units (RSUs), each representing a right to receive one share of the company’s common stock if vesting conditions are met.

The RSUs vest on the earlier of June 3, 2027 or the day immediately before the company’s next annual stockholder meeting following the grant date, provided she continues serving the company through that vesting date. After this grant, she holds 20,979 RSUs directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pire Shari Lisa

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	20,979	$0.00	--

Holdings After Transaction: Restricted Stock Units — 20,979 shares (Direct, null)

Footnotes (1)

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Key Figures

RSUs granted: 20,979 RSUs Exercise/award price: $0.0000 per unit Underlying shares: 20,979 shares +2 more

5 metrics

RSUs granted 20,979 RSUs Grant to director on June 3, 2026

Exercise/award price $0.0000 per unit RSU grant price

Underlying shares 20,979 shares Common stock underlying RSUs

Holdings after grant 20,979 RSUs Total RSUs following transaction

Vesting date trigger June 3, 2027 Earlier of this date or pre-next annual meeting

Key Terms

Restricted Stock Units, contingent right, vesting, annual meeting of stockholders

4 terms

Restricted Stock Units financial

"security_title: Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share"

vesting financial

"The RSUs vest on the earlier to occur of (i) June 3, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

annual meeting of stockholders financial

"the Issuer's next annual meeting of stockholders following the grant date"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/05/2026 - 07:36 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pire Shari Lisa

(Last)

(First)

(Middle)

C/O PRECISION BIOSCIENCES, INC.

302 E. PETTIGREW STREET, SUITE A-100

(Street)

DURHAM

NORTH CAROLINA

27701

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECISION BIOSCIENCES INC [ DTIL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	06/03/2026		A		20,979		⁽²⁾	⁽²⁾	Common Stock	20,979	$0	20,979	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

2. The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Remarks:

	/s/ Dario Scimeca, Attorney-in-Fact for Shari Lisa Pire	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did PRECISION BIOSCIENCES (DTIL) report for Shari Lisa Pire?

PRECISION BIOSCIENCES reported that director Shari Lisa Pire received 20,979 restricted stock units as an equity award. Each RSU represents a right to receive one share of common stock if vesting conditions are satisfied, reflecting routine director compensation.

How many restricted stock units did Shari Lisa Pire receive from PRECISION BIOSCIENCES (DTIL)?

Shari Lisa Pire received 20,979 restricted stock units from PRECISION BIOSCIENCES. These RSUs entitle her to receive 20,979 shares of common stock upon vesting, aligning her compensation with shareholder interests through equity-based incentives over time.

When do Shari Lisa Pire’s RSUs from PRECISION BIOSCIENCES (DTIL) vest?

The RSUs vest on the earlier of June 3, 2027 or the day immediately before PRECISION BIOSCIENCES’ next annual stockholder meeting after the grant. Vesting is conditioned on her continued service with the company through the applicable vesting date.

What does each RSU granted to Shari Lisa Pire by PRECISION BIOSCIENCES (DTIL) represent?

Each restricted stock unit represents a contingent right to receive one share of PRECISION BIOSCIENCES common stock. The shares are only delivered if the vesting conditions are met, so the award aligns long-term incentives rather than providing immediate share ownership.

Is Shari Lisa Pire’s PRECISION BIOSCIENCES (DTIL) RSU grant a purchase or a compensation award?

The 20,979 RSUs reported for Shari Lisa Pire are a compensation award, not an open-market purchase. They were granted at no cash cost per unit as part of her service as a director, subject to future vesting conditions.